The lab-drawn screening test from New Day Diagnostics is available without a doctor's order in most states and requires no special prep.
New Day Diagnostics today announced the launch of ColoHealth™, a groundbreaking blood test for colorectal cancer screening is now accessible to adults aged 50+who are at average risk. This test offers a non-invasive alternative for individuals who are unwilling or unable to undergo traditional screening methods such as colonoscopies or stool-based tests.This physician-mediated test is now available direct-to-consumer in all U.S. states except California and New York.
https://mma.prnewswire.com/media/2699518/Colohealth_Logo.jpg
ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening-Now Direct-to-Consumer
“ColoHealth™ is redefining what's possible in colorectal cancer screening by combining clinical rigor with real-world usability. With a sensitivity of 73.3%, specificity of 81.5%, and a negative predictive value of 99.8%, it provides both accuracy and reassurance,” noted Eric Mayer, CEO of New Day Diagnostics. “ColoHealth™ detect nearly twice as many pre-cancers as other colorectal screening blood tests.”
“What truly sets it apart is its ability to drive action-over 99% of individuals who previously refused other screenings completed the ColoHealth™ blood test. That kind of adherence is rare, and it translates to lives saved through earlier detection and intervention,” said Mayer.
ColoHealth™ eliminates many of the common barriers that prevent people from getting screened-there's no bowel prep, no anesthesia, and no need to take a day off work. It's a simple blood test that puts patients in control of their health.
A Streamlined, Three-Step Process
— Answer Health Questions:Consumers complete a brief medical questionnaire online to confirm eligibility.
— Order Online:Once approved, the test can be purchased securely at ColoHealthy.com. ColoHealth is currently available on a self-pay basis only.
— Schedule a Blood Draw:Patients select a local lab within New Day's phlebotomy network and schedule a blood draw at their convenience through an online portal.
If markers for colorectal cancer are detected, a follow-up colonoscopy will be required for diagnostic confirmation.
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. However, screening rates remain low, often due to the invasive nature or inconvenience of traditional procedures. ColoHealth™ aims to increase participation in routine screening by offering a simpler, more accessible option.
To learn more or order the test, visit www.ColoHealthy.com.
About New Day DiagnosticsNew Day Diagnostics is a health innovation company based in Knoxville, Tennessee, committed to making diagnostic testing more accessible, efficient and patient-friendly. Their mission is to make health information more accessible, accelerating the path from discovery to diagnosis when it is most critical to improving patient care and outcomes.
https://c212.net/c/img/favicon.png?sn=CL99431&sd=2025-05-29
View original content to download multimedia:https://www.prnewswire.com/news-releases/colohealth-blood-test-offers-a-simpler-first-step-in-colorectal-cancer-screeningnow-direct-to-consumer-302468954.html
SOURCE New Day Diagnostics
https://rt.newswire.ca/rt.gif?NewsItemId=CL99431&Transmission_Id=202505291817PR_NEWS_USPR_____CL99431&DateId=20250529